Clinical Trial Update: Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects [Phase 2]

View source ↗

Summary

Phase 2 randomized study assessing Velneperit and Orlistat, individually or with a reduced calorie diet, for efficacy and safety in obese subjects; the trial ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Orlistat (orlistat)
• Velneperit (S-2367) (Velneperit)

Snippet

Sponsor: Shionogi | Conditions: Obesity | Phase 2 | Status: COMPLETED